Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Clinical trial NCT02833714 · TERMINATED
Trial details
- NCT number
- NCT02833714
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-12-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.